<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01475942</url>
  </required_header>
  <id_info>
    <org_study_id>Turku_elderly</org_study_id>
    <nct_id>NCT01475942</nct_id>
  </id_info>
  <brief_title>Probiotic Intervention With Elderly Subjects</brief_title>
  <official_title>Randomized Placebo Controlled Study to Assess the Effect of a Probiotic Supplement on the Subclinical Levels of Intestinal C. Difficile Among Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danisco</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Danisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objective is to evaluate the effect of probiotic on faecal Clostridium difficile
      levels of elderly subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study objective is to evaluate the effect of a probiotic Lactobacillus strain in lowering
      the levels of Clostridium difficile in the intestine of elderly subjects. In addition, the
      nutritional and general health status will be assessed using validated health related
      questionnaires. Bowel function and prevalence of infections will be followed throughout the
      intervention period. The study population consists of elderly home inhabitants. The study
      will be conducted as a double-blind placebo-controlled trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in level of faecal Clostridium difficile</measure>
    <time_frame>0 weeks, 8 weeks, 16 weeks</time_frame>
    <description>Quantification of C. difficile from faecal samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in nutritional status</measure>
    <time_frame>0 weeks, 16 weeks</time_frame>
    <description>Evaluated according to the Mini Nutritional Assessment (MNA®) questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life</measure>
    <time_frame>0 weeks, 16 weeks</time_frame>
    <description>Evaluated according to the validated 15D© health related survey from adequately oriented subjects.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in levels of other intestinal pathogens than C. difficile</measure>
    <time_frame>0 weeks, 8 weeks, 16 weeks</time_frame>
    <description>Quantified from faecal samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in bowel function</measure>
    <time_frame>0 weeks, 16 weeks</time_frame>
    <description>Assessed according to Bristol Stool Form Scale by health care personnel throughout the study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">104</enrollment>
  <condition>Intestinal C. Difficile</condition>
  <arm_group>
    <arm_group_label>Probiotic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lactobacillus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sucrose</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic</intervention_name>
    <description>4 month probiotic intervention with 1 month run-in and 1 month wash-out. Probiotic given once a day.</description>
    <arm_group_label>Probiotic</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Lactobacillus</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elderly subjects

          -  no acute infection at recruitment

        Exclusion Criteria:

          -  antibiotic treatment 1 month prior to beginning of study

          -  less than 6 month life expectancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sampo Lahtinen, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Danisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anna Lyra, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Danisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matti Viitanen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Turku</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Elderly Home Kerttuli</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2011</study_first_submitted>
  <study_first_submitted_qc>November 17, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2011</study_first_posted>
  <last_update_submitted>January 26, 2016</last_update_submitted>
  <last_update_submitted_qc>January 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>elderly</keyword>
  <keyword>probiotic</keyword>
  <keyword>bowel function</keyword>
  <keyword>pathogen</keyword>
  <keyword>constipation</keyword>
  <keyword>diarrhoea</keyword>
  <keyword>Subclinical levels</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

